UW Health and the University of Wisconsin School of Medicine will enroll about 1,600 people over the next eight weeks at University Hospital to be part of a study on whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2.
Office of Strategic Communication